Netherlands Biologics Market (2025-2031) | Size, Segmentation, Revenue, Analysis, Companies, Growth, Share, Outlook, Value, Industry, Trends & Forecast

Name: Netherlands Biologics Market (2025-2031) | Trends & Industry
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Biologics Market, Netherlands Biologics Market, Netherlands Biologics Market Revenues, Netherlands Biologics Market Share, Netherlands Biologics Market Size, Netherlands Biologics Market Outlook, Netherlands Biologics Market Report, Netherlands Biologics Market Competition, Netherlands Biologics Market Overview, Netherlands Biologics Market Trends, Netherlands Biologics Market Forecast

Market Forecast By Source (Microbial, Mammalian, Others), By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy, Others), By Disease‚ Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), By Biologics Manufacturing (Outsourced, In-house) And Competitive Landscape

Product Code: ETC5821335	Publication Date: Nov 2023	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 60	No. of Figures: 30	No. of Tables: 5

Netherlands Biologics Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, the Netherlands continued to be a key player in biologics import, with Belgium, Hungary, USA, Japan, and Sweden as top exporting countries. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), indicating market dominance, the industry experienced a moderate CAGR of 3.85% from 2020 to 2024. However, there was a significant downturn in growth from 2023 to 2024, with a negative growth rate of -42.93%, which may warrant further analysis and strategic considerations for stakeholders in the biologics import market in the Netherlands.

Netherlands Biologics Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Netherlands Biologics Market Outlook
Market Size of Netherlands Biologics Market, 2024
Forecast of Netherlands Biologics Market, 2031
Historical Data and Forecast of Netherlands Biologics Revenues & Volume for the Period 2021-2031
Netherlands Biologics Market Trend Evolution
Netherlands Biologics Market Drivers and Challenges
Netherlands Biologics Price Trends
Netherlands Biologics Porter`s Five Forces
Netherlands Biologics Industry Life Cycle
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Source for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Microbial for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Mammalian for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Others for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Product Type for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Monoclonal Antibodies for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Vaccines for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Recombinant Proteins for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Antisense, RNAi, & Molecular Therapy for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Others for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Disease? Category for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Oncology for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Infectious Diseases for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Immunological Disorders for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Cardiovascular Disorders for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Hematological Disorders for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Others for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Biologics Manufacturing for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By Outsourced for the Period 2021-2031
Historical Data and Forecast of Netherlands Biologics Market Revenues & Volume By In-house for the Period 2021-2031
Netherlands Biologics Import Export Trade Statistics
Market Opportunity Assessment By Source
Market Opportunity Assessment By Product Type
Market Opportunity Assessment By Disease? Category
Market Opportunity Assessment By Biologics Manufacturing
Netherlands Biologics Top Companies Market Share
Netherlands Biologics Competitive Benchmarking By Technical and Operational Parameters
Netherlands Biologics Company Profiles
Netherlands Biologics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Netherlands Biologics Market Overview

3.1 Netherlands Country Macro Economic Indicators

3.2 Netherlands Biologics Market Revenues & Volume, 2021 & 2031F

3.3 Netherlands Biologics Market - Industry Life Cycle

3.4 Netherlands Biologics Market - Porter's Five Forces

3.5 Netherlands Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F

3.6 Netherlands Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 Netherlands Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F

3.8 Netherlands Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F

4 Netherlands Biologics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring biologics treatments

4.2.2 Technological advancements in biologics manufacturing and development

4.2.3 Strong government support for biologics research and development

4.3 Market Restraints

4.3.1 High costs associated with biologics manufacturing and development

4.3.2 Stringent regulatory requirements for biologics approval

4.3.3 Limited reimbursement policies for biologics treatments

5 Netherlands Biologics Market Trends

6 Netherlands Biologics Market Segmentations

6.1 Netherlands Biologics Market, By Source

6.1.1 Overview and Analysis

6.1.2 Netherlands Biologics Market Revenues & Volume, By Microbial, 2021-2031F

6.1.3 Netherlands Biologics Market Revenues & Volume, By Mammalian, 2021-2031F

6.1.4 Netherlands Biologics Market Revenues & Volume, By Others, 2021-2031F

6.2 Netherlands Biologics Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 Netherlands Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F

6.2.3 Netherlands Biologics Market Revenues & Volume, By Vaccines, 2021-2031F

6.2.4 Netherlands Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F

6.2.5 Netherlands Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F

6.2.6 Netherlands Biologics Market Revenues & Volume, By Others, 2021-2031F

6.3 Netherlands Biologics Market, By Disease? Category

6.3.1 Overview and Analysis

6.3.2 Netherlands Biologics Market Revenues & Volume, By Oncology, 2021-2031F

6.3.3 Netherlands Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F

6.3.4 Netherlands Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F

6.3.5 Netherlands Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F

6.3.6 Netherlands Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F

6.3.7 Netherlands Biologics Market Revenues & Volume, By Others, 2021-2031F

6.4 Netherlands Biologics Market, By Biologics Manufacturing

6.4.1 Overview and Analysis

6.4.2 Netherlands Biologics Market Revenues & Volume, By Outsourced, 2021-2031F

6.4.3 Netherlands Biologics Market Revenues & Volume, By In-house, 2021-2031F

7 Netherlands Biologics Market Import-Export Trade Statistics

7.1 Netherlands Biologics Market Export to Major Countries

7.2 Netherlands Biologics Market Imports from Major Countries

8 Netherlands Biologics Market Key Performance Indicators

8.1 Research and development investment in innovative biologics

8.2 Number of approved biologics in the market

8.3 Patient access and adoption rates of biologics treatments

8.4 Number of clinical trials for biologics conducted in the Netherlands

8.5 Collaboration and partnerships between biopharma companies and research institutions in the Netherlands

9 Netherlands Biologics Market - Opportunity Assessment

9.1 Netherlands Biologics Market Opportunity Assessment, By Source, 2021 & 2031F

9.2 Netherlands Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 Netherlands Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F

9.4 Netherlands Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F

10 Netherlands Biologics Market - Competitive Landscape

10.1 Netherlands Biologics Market Revenue Share, By Companies, 2024

10.2 Netherlands Biologics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Biologics Market

Asia Biologics Market

Asia Pacific Biologics Market

Europe Biologics Market

Global Biologics Market

North America Biologics Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here